News
03-04-2010, 05:40 AM
Celldex Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. Celldex reported a net loss of $13.5 million, or $0.43 per share, for the fourth quarter of 2009 compared to a net loss of $7.5 million, or $0.47 per share, for the fourth quarter of 2008.
More... (http://www.news-medical.net/news/20100304/Celldex-Therapeutics-reports-net-loss-of-24135M-for-fourth-quarter-of-2009.aspx)
More... (http://www.news-medical.net/news/20100304/Celldex-Therapeutics-reports-net-loss-of-24135M-for-fourth-quarter-of-2009.aspx)